Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00771537 · ClinicalTrials.gov registry record · Phase 3
HIV Testing & Womens Attitudes on HIV Vaccine Trials
A Phase 3 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 3
- Development phase
- 2,031
- Enrollment target
NCT00771537 is a Phase 3 study that has completed, run by Indiana University. The registered enrollment target is 2,031 participants.
The verdict
NCT00771537, a Phase 3 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,031 participants
- Enrollment target
Study Summary
The purpose of this study is to test the effects of different persuasive informational messages on rates of rapid HIV testing and willingness to participate in a HIV vaccine clinical trial. Adult African-American, non-Latina White, and Latina women will be recruited. Women will initially be randomized to 4 groups: 1. no message control; 2. 1-sided message that mentions benefits of HIV testing; 3. 2-sided message that acknowledges minor opposition to testing, then refutes the opposition; and 4. 2-sided message that acknowledge stronger opposition to testing, then refutes the opposition. Women will be offered HIV testing, then re-randomized to a similar set of 4 messages related to HIV vaccine trials. There will therefore be 16 groups in total (4 X 4).
Interventions
- BEHAVIORAL Message Sidedness
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,031 participants |
| Start Date | 2006-11 |
| Est. Completion | 2011-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00771537
The ClinicalTrials.gov registry entry for NCT00771537 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 2,031 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Message Sidedness is the first listed.
NCT00771537 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00771537 about?
NCT00771537 is a clinical study titled "HIV Testing & Womens Attitudes on HIV Vaccine Trials". The purpose of this study is to test the effects of different persuasive informational messages on rates of rapid HIV testing and willingness to participate in a HIV vaccine clinical trial. Adult African-American, non-Latina White, and Latina women will be recruited. Women will initially be randomiz...
What is the current status of trial NCT00771537?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,031 participants. The study started on 2006-11. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00771537?
The interventions under investigation include: Message Sidedness (BEHAVIORAL).
Who is sponsoring clinical trial NCT00771537?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.